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IntroductIon
Cardiovascular disease (CVD) has remained the leading cause 
of mortality in Brazil since the latter part of the 1960s.[1,2] 
Although effective tobacco control policies and access to 
improved healthcare have led to drastic improvements in 
cardiovascular health, an upwards trend in unhealthy eating 
habits and physical inactivity has been observed in the Brazilian 
population.[2] Smoking, obesity, hypertension, hyperlipidaemia 
and insulin resistance have long been recognised as major risk 
factors for CVDs;[3] however, the aetiology of CVD is not yet 
fully understood.[4] There has recently been renewed interest 
in the relationship between elevated homocysteine levels and 
the development of CVD.[5]
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Epidemiological studies have shown that hyperhomocysteinaemia 
is a well-known independent risk factor for atherosclerotic 
vascular disease and hypercoagulability states.[5] It is known to 
mediate adverse effects on vascular endothelium and smooth 
muscle cells.[6] In addition, hyperhomocysteinaemia reduces 
high-density lipoprotein (HDL) synthesis[7] and enhances 
the synthesis of lipoprotein A.[8] Some studies have indicated 
that up to 25% of coronary events may be attributed to the 
increase in homocysteine levels,[9] which have been shown to 
inversely correlate with B-complex vitamins, such as folate and 
Vitamin B12. Although B vitamins have a role in reducing blood 
homocysteine concentrations, the effect of these vitamins on 
cardiovascular function remains unclear.[10] A few studies have 
indicated that high folate and Vitamin B12 status are associated 
with a reduced risk of coronary heart disease.[11,12] Therefore, 
maintaining the concentrations of homocysteine, Vitamin B12, 
folate and lipids within the body is of grave importance.
The one-carbon metabolism pathway is a network of 
biochemical reactions involved in the transfer of single-carbon 
units (CH3 or methyl group), controlled by different enzymes 
and nutritional cofactors.[13] Cells require one-carbon units for 
nucleotide synthesis and methylation reactions. At present, 
common variants in genes of the one-carbon metabolism 
pathway have been reported to influence the concentrations 
of homocysteine, folate, Vitamin B12 and lipids.[14] A few 
studies have examined whether the association between 
genetic variants involved in the one-carbon metabolism 
pathway and homocysteine concentrations is modified by 
lifestyle factors such as diet.[15,16] However, no studies, to 
date, have examined the interaction between one-carbon 
metabolism-related genes and lifestyle factors on Vitamin 
B12, folate and lipid concentrations. Hence, seven genes 
involved in the one-carbon metabolism were selected for our 
study (betaine-homocysteine S-methyltransferase [BHMT], 
catechol-O-methyltransferase [COMT], fucosyltransferase 
2 [FUT2], methylenetetrahydrofolate reductase [MTHFR], 
5-methyltetrahydrofolate-homocysteine methyltransferase 
or methionine synthase [MTR], 5-methyltetrahydrofolate-
homocysteine methyltransferase reductase or methionine 
synthase reductase [MTRR] and transcobalamin 2 [TCN2]).
The aims of the present study were to determine whether ten 
single-nucleotide polymorphisms (SNPs) from seven selected 
candidate genes related to the one-carbon metabolism cycle 
were associated with Vitamin B12, homocysteine, folic acid 
and lipid-related outcomes and whether these associations were 
modified by environmental factors (diet and physical activity). 
Interaction and association analyses were carried out in 113 
adolescents with cardiovascular risk factors from the city of 
Goiânia, Goiás, Brazil.
MaterIals and Methods
Study participants
This cross-sectional study was conducted in a public school 
in the city of Goiânia, Goiás, Brazil, between March and 
May 2014. A total of 454 students were initially enrolled 
into the study, and 201 students were found to be eligible for 
participation. After screening through lifestyle, socioeconomic 
and clinical history, only 113 adolescents (aged 10–19 years) 
were selected to answer a food frequency record and provided 
a blood sample for biochemical and DNA analyses. Full details 
of the methodology have been explained previously.[17] Table 1 
shows the characteristics of the study participants.
Participants were selected on the basis that they were 
overweight/obese and/or were previously diagnosed 
with dyslipidaemia, but not with CVD.[17] The presence 
of dyslipidaemia was identified by the use of specific 
medications or when the interviewees reported having 
hypercholesterolaemia or hypertriglyceridemia, previously 
diagnosed by a physician. Individuals were not included in 
the study if they were previously diagnosed with CVD, they 
used lipid-lowering drugs and they were supplemented with 
folic acid, cobalamin and/or pyridoxine and/or nutritional 
treatment.
The present study was approved by the Federal University of 
Goiás (addendum in protocol number 422.329, 07/10/2013). 
Informed consent was obtained from all the study participants, 
and participants were allowed to leave the study at will and 
opt out from any of the procedures. Written informed consent 
was obtained from the study participants whose age was above 
18 years and, for those whose age was <18 years, consent 
was obtained from their parents or guardians. All clinical 
investigations were conducted according to the principles 
expressed in the Declaration of Helsinki.
Anthropometric and biochemical measurements
Details of anthropometric measurements have been described 
previously.[17] In brief, at baseline, all participants were 
measured for weight, height and waist circumference using 
standard study protocols. Body mass index (BMI) was 
estimated as weight (in kg) divided by the square of body 
height (m). BMI was classified according to the WHO (2007) 
classification for BMI/age according to sex.[18] Individuals 
below the 15th percentile were considered below normal 
weight, those between the 15th and 85th percentiles were 
classified as normal weight, those who fit between the 85th and 
97th percentiles were classified as overweight and those above 
the 97th percentile were considered obese.
For the determination of biochemical parameters, blood 
samples (12 ml) were collected by peripheral venous puncture 
in the morning, after a 12-h fast. The blood samples were 
used to measure homocysteine, Vitamin B12, folic acid, lipid 
profile (including oxidised low-density lipoprotein [ox-LDL]) 
concentrations and for DNA extraction. Vitamin B12 
and homocysteine concentrations were analysed using a 
chemiluminescence method. HDL-cholesterol (HDL-C) 
was determined after precipitation of the LDL and 
very-LDL (VLDL) fractions. The Friedewald formula was 
applied to obtain the measurement of LDL and VLDL 
cholesterol.[19] Plasma ox-LDL levels were measured 
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using commercially available sandwich enzyme-linked 
immunosorbent assay (Mercodia AB, Uppsala, Sweden).[20]
Assessment of dietary intake and physical activity
The study participants undertook a food consumption record 
by trained research staff. This method was used to collect 
participant’s usual food intake, highlighting household 
measures and portion sizes. All information provided by the 
participants was double checked for accuracy. Energy and 
nutrient intake from the recorded data were calculated based 
on the Avanutri® software (Avanutri Informática Ltda, Rio de 
Janeiro, Brazil), with emphasis on lipids, Vitamin B12 and 
folic acid. Wherever appropriate, nutrient intake values were 
adjusted to energy by the nutrient (energy adjusted) residual 
method.[21]
The Global Physical Activity Questionnaire, short form, was 
used to assess physical activity. Individuals were divided into 
physically active and inactive individuals.
Single‑nucleotide polymorphism selection and genotyping
The following ten common SNPs involved in the 
one-carbon metabolism pathway were selected based on 
the published reports:[16,22-26] rs1801133 (677C>T) and 
rs1801131 (1298A>C) of MTHFR; rs1805087 (2756A>G) of 
MTR; rs1801394 (66A>G) of MTRR; rs1801198 (776G>C) 
of TCN2; rs4680 (158G>A) and rs4633 of COMT; rs3797546 
and rs492842 of BHMT and rs602662 of FUT2. COMT 
rs4633,[13] MTHFR rs1801133 and MTHFR rs1801131 
SNPs[1-4] are essential variants known to influence circulating 
homocysteine. While variations in the BHMT gene may 
contribute to hyperhomocysteinaemia,[5] it is unknown whether 
the SNPs rs3797546 and rs492842 alter homocysteine levels. 
Previous studies indicate that the SNPs MTR rs1805087, 
MTRR rs1801394,[14] MTHFR rs1801133 and MTHFR 
rs1801131[1-4] are associated with folate concentrations. 
Furthermore, genome-wide significant associations with 
serum B12 have been reported for the SNPs TCN2 rs1801198[6] 
and FUT2 rs602662.[4,7] The most commonly studied, 
MTHFR SNP rs1801133, has shown associations with total 
cholesterol, HDL-C and LDL-cholesterol (LDL-C).[8,9] 
Finally, the COMT rs4680 SNP was found to be associated 
with triacylglycerol (TAG),[10,11] total cholesterol and LDL-C 
levels.[12]
DNA was then extracted from peripheral leucocytes in 
the blood, using a commercial kit (Roche™ Diagnostics 
GmbH, Mannheim, Germany) following the manufacturer’s 
guidelines accordingly. The purity and concentration of the 
DNA samples were assessed using a NanoDrop® ND-1000 
spectrophotometer (Thermo Scientific, Wilmington, 
NC, USA). The ten SNPs involved in the one-carbon 
metabolism were genotyped using real-time polymerase chain 
reaction using the QuantStudio™ OpenArray TaqMan™ 
platform (Life Technologies, Foster City, CA, USA) with 
personalised cards for 12K Flex system QuantStudio® 
(Life Technologies) with validated TaqMan Assay. The 
frequency of each SNP in this study sample was in agreement 
with the Hardy–Weinberg equilibrium (P > 0.05) [Table 2]. 
All analyses were performed by an experienced laboratory 
technician who was blinded to the details of the study 
participants.
Statistical analysis
Statistical analyses were carried out using the SPSS 
software (version 22; SPSS Inc., Chicago, IL, USA). Data 
distribution was verified by the Shapiro–Wilk test. Individuals 
with BMI of ≥25 kg/m2 were categorised as obese and those 
with a BMI of <25 kg/m2 were classified as non-obese. 
Descriptive statistics for continuous variables were shown 
Table 1: The characteristics of the study participants stratified by sex
All (n=113) Boys (n=47) Girls (n=66) P*
Age (years) 13.87±2.37 13.32±2.35 14.26±2.32 0.037
Height (m) 1.62±0.11 1.63±0.14 1.61±0.08 0.205
Weight (kg) 63.53±17.59 66.36±20.13 61.51±15.37 0.169
BMI (kg/m2) 24.01±4.92 24.33±5.07 23.79±4.84 0.567
Vitamin B12 (pg/ml) 519.80±232.15 534.62±252.96 509.24±217.50 0.569
Homocysteine (μmol/l) 7.04±2.99 7.90±2.91 6.42±2.92 0.009
Folic acid (ng/ml) 11.02±3.27 10.78±3.62 11.20±3.01 0.519
TAG (mg/dl) 94.05±54.16 99.00±59.00 90.53±50.61 0.415
Total cholesterol (mg/dl) 155.42±26.34 150.47±24.51 158.95±27.20 0.091
HDL (mg/dl) 46.29±11.79 43.60±11.47 48.21±11.72 0.040
LDL (mg/dl) 90.28±21.00 87.04±18.19 92.59±22.64 0.167
VLDL (mg/dl) 18.85±10.82 19.83±11.75 18.15±10.15 0.419
Oxidised-LDL (U/L) 6.42±13.69 5.92±11.47 6.77±15.12 0.749
Total energy (kcal/day) 2521.63±585.84 3010.08±594.92 2173.79±213.40 <0.0001
Carbohydrate intake (energy %) 47.70±20.59 40.86±19.56 52.56±20.05 0.003
Fat intake (energy %) 25.36±13.22 22.84±11.58 27.16±14.09 0.087
Protein intake (energy %) 16.99±8.38 14.56±6.94 18.72±8.92 0.006
*P values showing the differences in mean values between boys and girls. Data presented as mean±SD. P values were calculated by using Independent 
t-test. BMI: Body mass index, LDL: Low-density lipoprotein, HDL: High-density lipoprotein, VLDL: Very low-density lipoprotein, TAG: Triacylglycerol
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as means and standard deviation (SD). The mean differences 
between continuous variables and the genotypes were analysed 
by the independent sample t-test.
Linear regression was used to examine the association of 
the SNPs involved in the one-carbon metabolism pathway 
with Vitamin B12, folic acid, homocysteine and lipid 
concentrations (TAG, HDL-C, LDL-C and ox-LDL). 
The interaction between the SNPs and dietary factors on 
determining Vitamin B12, folic acid, homocysteine and lipid 
concentrations was determined by including the interaction 
term (SNP * diet) in the general linear regression models. 
Models were adjusted for age, sex, BMI and total energy intake, 
wherever appropriate. The dominant model was applied only for 
those SNPs which had a frequency of rare homozygotes ≤19%. 
Correction for multiple testing was applied using Bonferroni 
correction (adjusted P value for association was <0.00071 
[10 SNPs *7 outcomes (B12, folic acid, homocysteine, TAG, 
HDL-C, LDL-C and ox-LDL concentrations) = 70 tests]) 
and for interaction <0.00018 (10 SNPs *7 outcomes [B12, 
folic acid, homocysteine, TAG, HDL-C, LDL-C and ox-LDL 
concentrations] *4 lifestyle factors = 280 tests). All data were 
expressed as mean ± SD.
Power calculation
Given that there were no previously reported effect sizes, we 
were unable to perform a power calculation. However, based 
on the effect sizes that were observed for the associations, 
we performed a retrospective power calculation using the 
Quanto software, version 1.2.4 (May 2009, Department of 
Preventive Medicine, Keck School of Medicine, University 
of Southern California, 2001 N Soto Street, Los Angeles, CA 
90032). Power calculations were carried out in the form of 
least detectable effects based on the assumption of significance 
levels and powers of 5% and 80%, respectively. At 80% 
power, the minimum detectable effects ranged from beta 7.5 
U/L (ox-LDL) for a SNP with minor allele frequency (MAF) 
of 15% to beta 8.5 U/L for a SNP with MAF 50% for a sample 
size of 113 individuals.
results
Characteristics of the participants
The clinical characteristics of the studied population are shown 
in Table 1. The sample consisted of 47 boys and 66 girls. The 
mean age ± SD of the student group was 13.32 ± 2.35 years 
for boys and 14.26 ± 2.32 years for girls. When the metabolite 
means were categorised by sex, plasma homocysteine and 
HDL concentrations were found to show significant differences 
between boys and girls (P = 0.009 and P = 0.040, respectively). 
In the study population, dietary intake of carbohydrate 
(energy %) and protein intake (energy %) were higher in girls 
than boys (P = 0.003 and P = 0.006, respectively), while there 
was no significant difference observed (P = 0.087) in dietary 
intake of fat (energy %) between girls and boys [Table 1].
Association between single‑nucleotide polymorphisms 
and Vitamin B12, folic acid, homocysteine and lipid traits
When analysing associations between ten SNPs involved in genes 
related to the one-carbon metabolism cycle and biochemical 
indexes, we found that COMT rs4633 was significantly 
associated with folic acid (Passociation = 0.042). Folic acid was 
significantly lower in CC common homozygous individuals 
(10.25 ± 2.99 ng/ml) than in pooled TT and CC individuals 
(11.67 ± 3.29 ng/ml) (Passociation = 0.042) [Table 3]. Furthermore, 
homozygosity for the G allele at the FUT2 rs602662 SNP was 
significantly associated with lower Vitamin B12 concentrations 
compared with the wild-type group where Vitamin B12 
concentrations were 24.27% lower in GG individuals than in 
AA individuals (Passociation = 0.009) [Table 3]. In addition to 
these findings, the minor allele (G) of the MTRR rs1801394 
SNP was significantly associated with elevated ox-LDL levels 
(Passociation = 0.041) [Table 3]. After Bonferroni correction, none of 
the results were considered statistically significant (P > 0.00071).
Interaction between single‑nucleotide polymorphisms and 
Vitamin B12, folic acid and homocysteine
An interaction was observed between the BHMT SNP rs492842 
and dietary fat intake on Vitamin B12 levels (P = 0.034). 
In addition, further interactions were found between the 
Table 2: Genotype distribution of single‑nucleotide polymorphisms involved in the one carbon‑metabolism pathway
Gene 
symbol
SNP 
rs number
Major allele/ 
minor allele
Common 
homozygotes (%)
Heterozygotes (%) Rare 
homozygotes (%)
Minor allele 
frequency
HWE (P)
MTHFR rs1801131 A/C 56 (49.9) 43 (38.1) 13 (11.5) 0.31 0.29
MTHFR rs1801133 C/T 55 (48.7) 41 (36.3) 12 (10.6) 0.30 0.31
MTR rs1805087 A/G 77 (68.1) 32 (28.3) 2 (1.8) 0.16 0.52
MTRR rs1801394 A/G 45 (39.8) 49 (43.4) 16 (14.2) 0.37 0.66
TCN2 rs1801198 G/C 60 (53.1) 33 (29.2) 10 (8.8) 0.26 0.10
COMT rs4680 G/A 35 (31) 48 (42.5) 24 (21.2) 0.45 0.33
COMT rs4633 C/T 44 (38.9) 51 (45.1) 16 (14.2) 0.37 0.84
BHMT rs3797546 T/C 67 (59.3) 27 (23.9) 7 (6.2) 0.20 0.08
BHMT rs492842 T/C 35 (31) 43 (38.1) 27 (23.9) 0.46 0.07
FUT2 rs602662 G/A 34 (30.1) 52 (46.0) 24 (21.2) 0.45 0.62
MTHFR: Methylene tetrahydrofolate reductase, MTR: 5-methyltetrahydrofolate-homocysteine methyltransferase, 
MTRR: 5-methyltetrahydrofolate-homocysteine methyltransferase reductase, TCN2: Transcobalamin 2, COMT: Catechol-O-methyltransferase, 
BHMT: Betaine-homocysteine methyltransferase, FUT2: Fucosyltransferase 2, HWE: Hardy–Weinberg equilibrium, SNPs: Single-nucleotide polymorphisms
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Table 3: Association between single‑nucleotide polymorphisms involved in the one‑carbon metabolism pathway and 
Vitamin B12, homocysteine, folic acid and lipid traits
SNPs MAF Vitamin B12 
(pg/ml)
Homocysteine 
(μmol/l)
Folic acid 
(ng/ml)
High‑density 
lipoprotein 
cholesterol 
(mmol/l)
Low‑density 
lipoprotein 
cholesterol 
(mmol/l)
Triglycerides 
(mmol/l)
Oxidised‑low 
density lipoprotein 
cholesterol (U/L)
MTHFR gene 
(rs1801131)
0.31
AA 524.23±223.49 6.90±2.96 11.26±3.34 47.18±12.84 87.55±21.54 95.05±62.54 7.90±18.65
A/C 520.21±241.74 7.19±3.07 10.87±3.20 45.68±10.60 92.54±20.21 92.73±45.32 5.07±5.67
Dominant model 
(AA vs. AC + CC)
P
0.916 0.895 0.682 0.708 0.180 0.739 0.209
MTHFR gene 
(rs1801133)
0.30
CC 562.36±238.63 6.80±3.00 11.51±3.18 46.04±10.33 90.67±22.87 86.33±46.07 4.28±5.21
C/T 491.42±224.74 7.37±3.00 10.75±3.37 46.25±13.14 89.08±19.51 100.26±61.36 8.95±19.12
Dominant model 
(CC vs. CT + TT)
P
0.058 0.100 0.158 0.468 0.519 0.300 0.106
MTR gene 
(rs1805087)
0.16
AA 523.97±221.74 7.22±3.29 11.03±3.31 46.64±12.73 89.42±20.73 92.83±58.11 6.70±14.34
A/G 518.59±518.59 6.77±2.21 11.08±3.27 45.82±9.78 91.71±22.29 95.44±46.26 6.01±12.72
Dominant model 
(AA vs. AG + 
GG)
P
0.815 0.301 0.919 0.886 0.517 0.893 0.836
MTRR gene 
(rs1801394)
0.37
AA 560.53±249.40 6.61±2.58 10.96±3.42 46.29±9.67 90.78±23.02 93.98±62.30 3.13±3.81
A/G 494.11±218.14 7.35±3.27 11.14±3.20 46.38±13.09 89.60±19.91 93.28±48.75 8.95±17.46
Dominant model 
(AA vs. AG + 
GG)
P
0.265 0.394 0.508 0.827 0.814 0.958 0.041
TCN2 gene 
(rs1801198)
0.26
GG 523.88±221.89 6.99±2.60 11.34±3.26 46.93±12.74 90.70±22.25 91.88±50.19 5.99±13.23
G/C 530.67±263.13 6.94±3.16 10.67±3.14 44.95±9.83 90.09±19.48 98.53±61.99 7.82±15.69
Dominant model 
(GG vs. GC + CC)
P
0.982 0.751 0.231 0.213 0.776 0.463 0.497
COMT gene 
(rs4680)
0.45
GG 495.54±234.10 6.98±3.20 10.02±2.81 44.00±10.67 86.71±20.17 102.14±65.53 5.14±6.30
GA 546.98±249.81 6.88±2.32 11.56±3.24 45.58±11.29 87.71±22.27 95.27±57.18 7.07±17.47
AA 515.50±181.22 7.08±3.94 11.59±3.61 49.21±13.83 96.83±17.83 81.13±27.52 7.20±14.86
Additive model
P
0.825 0.843 0.094 0.258 0.186 0.376 0.658
COMT gene 
(rs4633)
0.37
CC 511.77±248.82 6.98±3.28 10.25±2.99 45.05±10.87 87.91±19.92 99.84±61.18 4.99±6.00
C/T 532.07±221.84 7.00±2.77 11.67±3.29 47.25±12.36 90.99±21.46 89.36±49.63 7.54±17.11
Dominant model 
(CC vs. CT + TT)
P
0.907 0.740 0.042 0.524 0.337 0.364 0.146
BHMT gene 
(rs3797546)
0.20
Contd...
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FUT2 SNP rs602662 with dietary protein intake (P = 0.007) 
and carbohydrate intake (P = 0.031) on homocysteine 
concentrations [Table 4]. We found that rare AA homozygotes 
of the FUT2 SNP rs602662 had higher homocysteine 
levels (mean ± standard error [SE]: 8.038 ± 0.896 μmol/L) 
compared to the GG allele carriers (mean ± SE: 5.857 ± 1.039 
μmol/L) among those in the highest tertile of protein 
intake (mean ± SE: 148.618 ± 5.777 g/day); however, the 
difference in the means of homocysteine concentrations 
between the genotype groups in the highest tertile of protein 
intake was not statistically significant (P = 0.227), which could 
be because of the small sample size.
Interaction between single‑nucleotide polymorphisms and 
dietary factors on lipid concentrations
Interactions were observed between the COMT SNPs 
(rs4680 and rs4633) and dietary carbohydrate intake on 
HDL-C concentrations (P = 0.011 and P = 0.036, respectively). 
Furthermore, an interaction was found between the COMT SNP 
(rs4680) and dietary carbohydrate intake on ox-LDL concentrations 
(P = 0.005) [Table 5]. However, none of the interactions between 
the SNPs and dietary intake on lipid outcomes reached statistical 
significance after correction for multiple testing.
Gene–physical activity interactions on Vitamin B12, folic 
acid, homocysteine and lipid profile
No statistically significant interactions were observed after 
correction for multiple testing between the ten SNPs and 
physical activity on Vitamin B12, folic acid, homocysteine 
and lipid traits (Pinteraction > 0.00018) [Supplementary Table 1].
dIscussIon
To our knowledge, this is the first genetic epidemiological study 
to investigate the interactions between SNPs involved in the 
one-carbon metabolism pathway and environmental/lifestyle 
factors on Vitamin B12, folic acid, homocysteine and lipid 
levels (HDL-C, LDL, TAG and ox-LDL) in the Brazilian 
adolescent population. Our study provides evidence for 
novel interactions between SNP rs4680 (COMT gene) 
and carbohydrate intake on ox-LDL levels and the SNP 
rs602662 (FUT2 gene) and protein intake on homocysteine 
concentrations in Brazilian adolescents. Given that ox-LDL 
and hyperhomocysteinaemia are well-known independent risk 
factors for atherosclerotic vascular disease,[5,27] our findings 
have significant public health implications.
Genes involved in one-carbon metabolism are of particular 
interest because of their role in CVDs.[28] From the ten 
SNPs which were investigated in this study, association 
of the SNP rs4633 at the COMT gene with folic acid 
concentrations (P = 0.042), the SNP rs602662 at the 
FUT2 gene with Vitamin B12 levels (P = 0.009) and 
finally the SNP rs1801394 at the MTRR gene with ox-LDL 
concentrations (P = 0.041) was observed. Even though the 
findings were not significant after Bonferroni correction, the 
Table 3: Contd...
SNPs MAF Vitamin B12 
(pg/ml)
Homocysteine 
(μmol/l)
Folic acid 
(ng/ml)
High‑density 
lipoprotein 
cholesterol 
(mmol/l)
Low‑density 
lipoprotein 
cholesterol 
(mmol/l)
Triglycerides 
(mmol/l)
Oxidised‑low 
density lipoprotein 
cholesterol (U/L)
TT 536.31±233.97 7.04±3.18 11.51±3.33 46.21±11.33 89.57±21.17 94.55±56.16 6.68±15.25
T/C 523.41±224.50 6.53±2.03 10.54±2.90 46.59±12.48 92.18±21.76 99.29±54.96 6.74±12.72
Dominant model
(TT vs. TC + CC)
P
0.971 0.151 0.231 0.461 0.495 0.811 0.791
BHMT gene 
(rs492842)
0.46
TT 554.89±254.53 6.65±2.66 11.92±3.21 47.57±11.81 85.91±24.16 90.83±43.39 6.47±12.79
TC 492.35±196.18 7.64±3.30 10.14±3.16 45.77±10.46 93.84±17.92 97.05±55.94 8.74±18.36
CC 469.70±201.74 6.91±3.14 11.27±3.35 44.26±11.06 89.37±21.64 99.07±68.56 3.34±4.95
Additive model
P
0.293 0.602 0.095 0.872 0.179 0.915 0.220
FUT2 gene 
(rs602662)
0.45
GG 471.41±193.77 6.93±3.35 11.47±3.31 44.68±10.01 84.50±20.31 90.12±54.27 8.21±13.26
GA 494.73±220.75 7.18±2.46 10.69±3.19 47.21±13.38 90.52±20.81 93.40±54.93 4.99±13.69
AA 622.50±268.60 6.84±3.64 11.15±3.40 46.29±10.37 97.79±21.98 104.17±56.13 7.42±15.24
Additive model
P
0.009 0.677 0.620 0.622 0.063 0.664 0.374
Values are given as mean±SD. P values for differences between genotypes were obtained using linear regression model adjusted for age, sex and BMI. 
Adjusted P value after correction for multiple testing was 0.00071. MAF: Minor allele frequency, MTHFR: Methylene tetrahydrofolate reductase, 
MTR: 5-methyltetrahydrofolate-homocysteine methyltransferase, MTRR: 5-methyltetrahydrofolate-homocysteine methyltransferase reductase, 
TCN2: Transcobalamin 2, COMT: Catechol-O-methyltransferase, BHMT: Betaine-homocysteine methyltransferase, FUT2: Fucosyltransferase 2, 
SNPs: Single-nucleotide polymorphisms, SD: Standard deviation
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Table 4: Interaction between single‑nucleotide polymorphisms and dietary factors on Vitamin B12, homocysteine and 
folic acid traits
P values for the interaction between SNPs and dietary factors on Vitamin B12
Interaction between SNP rs1801131* fat 
energy intake
Interaction between SNP rs1801131* protein 
energy intake
Interaction between SNP rs1801131* 
carbohydrate energy intake
0.685 0.095 0.074
Interaction between SNP rs1801133* fat 
energy intake
Interaction between SNP rs1801133* protein 
energy intake
Interaction between SNP rs1801133* 
carbohydrate energy intake
0.429 0.067 0.115
Interaction between SNP rs1805087* fat 
energy intake
Interaction between SNP rs1805087* protein 
energy intake
Interaction between SNP rs1805087* 
carbohydrate energy intake
0.368 0.539 0.206
Interaction between SNP rs1801394* fat 
energy intake
Interaction between SNP rs1801394* protein 
energy intake
Interaction between SNP rs1801394* 
carbohydrate energy intake
0.733 0.070 0.743
Interaction between SNP rs1801198* fat 
energy intake
Interaction between SNP rs1801198* protein 
energy intake
Interaction between SNP rs1801198* 
carbohydrate energy intake
0.789 0.109 0.631
Interaction between SNP rs4680* fat energy 
intake
Interaction between SNP rs4680* protein 
energy intake
Interaction between SNP rs4680* carbohydrate 
energy intake
0.662 0.265 0.559
Interaction between SNP rs4633* fat energy 
intake 
Interaction between SNP rs4633* protein 
energy intake
Interaction between SNP rs4633* carbohydrate 
energy intake
0.455 0.490 0.799
Interaction between SNP rs3797546* fat 
energy intake
Interaction between SNP rs3797546* protein 
energy intake
Interaction between SNP rs3797546* 
carbohydrate energy intake
0.353 0.979 0.281
Interaction between SNP rs492842* fat 
energy intake
Interaction between SNP rs492842* protein 
energy intake
Interaction between SNP rs492842* 
carbohydrate energy intake
0.034 0.678 0.331
Interaction between SNP rs602662* fat 
energy intake
Interaction between SNP rs602662* protein 
energy intake
Interaction between SNP rs602662* 
carbohydrate energy intake
0.087 0.144 0.533
P values for the interaction between SNPs and dietary factors on homocysteine
Interaction between SNP rs1801131* fat 
energy intake
Interaction between SNP rs1801131* protein 
energy intake
Interaction between SNP rs1801131* 
carbohydrate energy intake
0.806 0.803 0.625
Interaction between SNP rs1801133* fat 
energy intake
Interaction between SNP rs1801133* protein 
energy intake
Interaction between SNP rs1801133* 
carbohydrate energy intake
0.975 0.621 0.433
Interaction between SNP rs1805087* fat 
energy intake
Interaction between SNP rs1805087* protein 
energy intake
Interaction between SNP rs1805087* 
carbohydrate energy intake
0.123 0.922 0.389
Interaction between SNP rs1801394* fat 
energy intake
Interaction between SNP rs1801394* protein 
energy intake
Interaction between SNP rs1801394* 
carbohydrate energy intake
0.252 0.645 0.456
Interaction between SNP rs1801198* fat 
energy intake
Interaction between SNP rs1801198* protein 
energy intake
Interaction between SNP rs1801198* 
carbohydrate energy intake
0.869 0.212 0.341
Interaction between SNP rs4680* fat energy 
intake
Interaction between SNP rs4680* protein 
energy intake
Interaction between SNP rs4680* carbohydrate 
energy intake
0.062 0.189 0.054
Interaction between SNP rs4633* fat energy 
intake
Interaction between SNP rs4633* protein 
energy intake
Interaction between SNP rs4633* carbohydrate 
energy intake
0.596 0.359 0.133
Interaction between SNP rs3797546* fat 
energy intake
Interaction between SNP rs3797546* protein 
energy intake
Interaction between SNP rs3797546* 
carbohydrate energy intake
0.713 0.614 0.209
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Table 4: Contd...
P values for the interaction between SNPs and dietary factors on homocysteine
Interaction between SNP rs492842* fat 
energy intake
Interaction between SNP rs492842* protein 
energy intake
Interaction between SNP rs492842* 
carbohydrate energy intake
0.232 0.227 0.606
Interaction between SNP rs602662* fat 
energy intake
Interaction between SNP rs602662* protein 
energy intake
Interaction between SNP rs602662* 
carbohydrate energy intake
0.334 0.007 0.031
P values for the interaction between SNPs and dietary factors on folic acid
Interaction between SNP rs1801131 * fat 
energy intake
Interaction between SNP rs1801131* protein 
energy intake
Interaction between SNP rs1801131* 
carbohydrate energy intake
0.378 0.642 0.774
Interaction between SNP rs1801133* fat 
energy intake
Interaction between SNP rs1801133* protein 
energy intake
Interaction between SNP rs1801133* 
carbohydrate energy intake
0.595 0.587 0.722
Interaction between SNP rs1805087* fat 
energy intake
Interaction between SNP rs1805087* protein 
energy intake
Interaction between SNP rs1805087* 
carbohydrate energy intake
0.834 0.887 0.498
Interaction between SNP rs1801394* fat 
energy intake
Interaction between SNP rs1801394* protein 
energy intake
Interaction between SNP rs1801394* 
carbohydrate energy intake
0.641 0.826 0.327
Interaction between SNP rs1801198* fat 
energy intake
Interaction between SNP rs1801198* protein 
energy intake
Interaction between SNP rs1801198* 
carbohydrate energy intake
0.845 0.759 0.547
Interaction between SNP rs4680* fat energy 
intake
Interaction between SNP rs4680* protein 
energy intake
Interaction between SNP rs4680* carbohydrate 
energy intake
0.610 0.495 0.228
Interaction between SNP rs4633* fat energy 
intake
Interaction between SNP rs4633* protein 
energy intake
Interaction between SNP rs4633* carbohydrate 
energy intake
0.721 0.248 0.050
Interaction between SNP rs3797546* fat 
energy intake
Interaction between SNP rs3797546* protein 
energy intake
Interaction between SNP rs3797546* 
carbohydrate energy intake
0.188 0.394 0.754
Interaction between SNP rs492842* fat 
energy intake
Interaction between SNP rs492842* protein 
energy intake
Interaction between SNP rs492842* 
carbohydrate energy intake
0.084 0.971 0.447
Interaction between SNP rs602662* fat 
energy intake
Interaction between SNP rs602662* protein 
energy intake
Interaction between SNP rs602662* 
carbohydrate energy intake
0.521 0.775 0.115
P values were obtained by using a general linear model adjusted for age, sex and BMI. SNPs: Single-nucleotide polymorphisms, BMI: Body mass index
association between the FUT2 SNP rs602662 and Vitamin B12 
concentrations is in accordance with previous studies.[14,22,29-33] 
Since the current sample size is relatively small, further 
studies utilising a larger sample size are required to confirm 
the observed associations.
To date, only one study has shown a gene–diet interaction on 
ox-LDL concentrations in a population from the Attica region in 
Greece.[34] In this study, there was an interaction of the MTHFR 
SNP rs1801133 with the Mediterranean diet on ox-LDL 
concentrations. A high adherence to the Mediterranean diet was 
found to be associated with decreased ox-LDL concentrations 
in T allele carriers of SNP rs1801133.[34] Further to this, many 
studies have reported that MTHFR variants (C677T and 
A1298C) are linked to higher homocysteine levels when folate 
consumption is low.[35,36] In the present study, we identified 
significant gene–diet interactions between SNP rs4680 at the 
COMT gene and carbohydrate intake on ox-LDL concentrations 
and the SNP rs602662 at the FUT2 gene and protein intake on 
homocysteine concentrations. However, further stratification of 
participants based on their consumption of low-, medium- and 
high-dietary carbohydrate/protein did not show a statistically 
significant association between the SNP and the outcome in 
any of the tertiles, which could account for the small sample 
size. This is the first study to provide evidence for gene–diet 
interactions at the COMT and FUT2 gene loci, on ox-LDL and 
homocysteine concentrations, respectively, and hence, we do 
not have any previous studies to compare our findings.
Total carbohydrate intake has increased considerably in Brazil 
in the last few decades.[37] Data from two population-based 
surveys conducted in women over 35 years of age from Rio 
de Janeiro reported that the carbohydrate intake has increased 
from 352 g (95% confidence interval [CI]: 325–382) in 1995 
to 437 g (95% CI: 415–458) in 2005.[37] Interestingly, our 
study in this Brazilian adolescent population has identified 
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Table 5: Interaction between single‑nucleotide polymorphisms and dietary factors on lipid traits
Interaction between SNPs and dietary factors on HDL‑C
Interaction between SNP rs1801131 * fat 
energy intake
Interaction between SNP rs1801131* protein 
energy intake
Interaction between SNP rs1801131* 
carbohydrate energy intake
0.964 0.402 0.899
Interaction between SNP rs1801133* fat energy 
intake
Interaction between SNP rs1801133* protein 
energy intake
Interaction between SNP rs1801133* 
carbohydrate energy intake
0.393 0.471 0.994
Interaction between SNP rs1805087* fat energy 
intake
Interaction between SNP rs1805087* protein 
energy intake
Interaction between SNP rs1805087* 
carbohydrate energy intake
0.651 0.298 0.499
Interaction between SNP rs1801394* fat energy 
intake
Interaction between SNP rs1801394* protein 
energy intake
Interaction between SNP rs1801394* 
carbohydrate energy intake
0.896 0.712 0.676
Interaction between SNP rs1801198* fat energy 
intake
Interaction between SNP rs1801198* protein 
energy intake
Interaction between SNP rs1801198* 
carbohydrate energy intake
0.414 0.822 0.649
Interaction between SNP rs4680* fat energy 
intake
Interaction between SNP rs4680* protein 
energy intake
Interaction between SNP rs4680* carbohydrate 
energy intake
0.898 0.536 0.011
Interaction between SNP rs4633* fat energy 
intake
Interaction between SNP rs4633* protein 
energy intake
Interaction between SNP rs4633* carbohydrate 
energy intake
0.846 0.620 0.036
Interaction between SNP rs3797546* fat energy 
intake
Interaction between SNP rs3797546* protein 
energy intake
Interaction between SNP rs3797546* 
carbohydrate energy intake
0.274 0.162 0.555
Interaction between SNP rs492842 fat energy 
intake
Interaction between SNP rs492842* protein 
energy intake
Interaction between SNP rs492842* carbohydrate 
energy intake
0.604 0.960 0.513
Interaction between SNP rs602662* fat energy 
intake
Interaction between SNP rs602662* protein 
energy intake
Interaction between SNP rs602662* carbohydrate 
energy intake
0.650 0.123 0.813
Interaction between SNPs and dietary factors on LDL‑C
Interaction between SNP rs1801131 * fat 
energy intake
Interaction between SNP rs1801131* protein 
energy intake
Interaction between SNP rs1801131* 
carbohydrate energy intake
0.529 0.467 0.798
Interaction between SNP rs1801133* fat energy 
intake
Interaction between SNP rs1801133* protein 
energy intake
Interaction between SNP rs1801133* 
carbohydrate energy intake
0.640 0.656 0.737
Interaction between SNP rs1805087* fat energy 
intake
Interaction between SNP rs1805087* protein 
energy intake
Interaction between SNP rs1805087* 
carbohydrate energy intake
0.456 0.933 0.876
Interaction between SNP rs1801394* fat energy 
intake
Interaction between SNP rs1801394* protein 
energy intake
Interaction between SNP rs1801394* 
carbohydrate energy intake
0.487 0.384 0.222
Interaction between SNP rs1801198* fat energy 
intake
Interaction between SNP rs1801198* protein 
energy intake
Interaction between SNP rs1801198* 
carbohydrate energy intake
0.127 0.664 0.250
Interaction between SNP rs4680* fat energy 
intake
Interaction between SNP rs4680* protein 
energy intake
Interaction between SNP rs4680* carbohydrate 
energy intake
0.509 0.709 0.299
Interaction between SNP rs4633* fat energy 
intake
Interaction between SNP rs4633* protein 
energy intake
Interaction between SNP rs4633* carbohydrate 
energy intake
0.743 0.915 0.067
Interaction between SNP rs3797546* fat energy 
intake
Interaction between SNP rs3797546* protein 
energy intake
Interaction between SNP rs3797546* 
carbohydrate energy intake
0.594 0.097 0.306
Interaction between SNP rs492842* fat energy 
intake
Interaction between SNP rs492842* protein 
energy intake
Interaction between SNP rs492842* carbohydrate 
energy intake
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Table 5: Contd...
Interaction between SNPs and dietary factors on LDL‑C
0.380 0.392 0.402
Interaction between SNP rs602662* fat energy 
intake
Interaction between SNP rs602662* protein 
energy intake
Interaction between SNP rs602662* carbohydrate 
energy intake
0.399 0.462 0.610
Interaction between SNPs and dietary factors on triglycerides
Interaction between SNP rs1801131 * fat 
energy intake
Interaction between SNP rs1801131* protein 
energy intake
Interaction between SNP rs1801131* 
carbohydrate energy intake
0.970 0.792 0.504
Interaction between SNP rs1801133* fat energy 
intake
Interaction between SNP rs1801133* protein 
energy intake
Interaction between SNP rs1801133* 
carbohydrate energy intake
0.938 0.798 0.266
Interaction between SNP rs1805087* fat energy 
intake
Interaction between SNP rs1805087* protein 
energy intake
Interaction between SNP rs1805087* 
carbohydrate energy intake
0.648 0.362 0.245
Interaction between SNP rs1801394* fat energy 
intake
Interaction between SNP rs1801394* protein 
energy intake
Interaction between SNP rs1801394* 
carbohydrate energy intake
0.176 0.285 0.857
Interaction between SNP rs1801198* fat energy 
intake
Interaction between SNP rs1801198* protein 
energy intake
Interaction between SNP rs1801198* 
carbohydrate energy intake
0.490 0.719 0.317
Interaction between SNP rs4680* fat energy 
intake
Interaction between SNP rs4680* protein 
energy intake
Interaction between SNP rs4680* carbohydrate 
energy intake
0.290 0.408 0.923
Interaction between SNP rs4633* fat energy 
intake
Interaction between SNP rs4633* protein 
energy intake
Interaction between SNP rs4633* carbohydrate 
energy intake
0.185 0.220 0.770
Interaction between SNP rs3797546* fat energy 
intake
Interaction between SNP rs3797546* protein 
energy intake
Interaction between SNP rs3797546* 
carbohydrate energy intake
0.127 0.741 0.457
Interaction between SNP rs492842* fat energy 
intake
Interaction between SNP rs492842* protein 
energy intake
Interaction between SNP rs492842* carbohydrate 
energy intake
0.237 0.216 0.989
Interaction between SNP rs602662* fat energy 
intake
Interaction between SNP rs602662* protein 
energy intake
Interaction between SNP rs602662* carbohydrate 
energy intake
0.360 0.082 0.817
Interaction between SNPs and dietary factors on LDL‑ox
Interaction between SNP rs1801131 * fat 
energy intake
Interaction between SNP rs1801131* protein 
energy intake
Interaction between SNP rs1801131* 
carbohydrate energy intake
0.161 0.962 0.582
Interaction between SNP rs1801133* fat energy 
intake
Interaction between SNP rs1801133* protein 
energy intake
Interaction between SNP rs1801133* 
carbohydrate energy intake
0.399 0.972 0.908
Interaction between SNP rs1805087* fat energy 
intake
Interaction between SNP rs1805087* protein 
energy intake
Interaction between SNP rs1805087* 
carbohydrate energy intake
0.493 0.126 0.784
Interaction between SNP rs1801394* fat energy 
intake
Interaction between SNP rs1801394* protein 
energy intake
Interaction between SNP rs1801394* 
carbohydrate energy intake
0.235 0.781 0.672
Interaction between SNP rs1801198* fat energy 
intake
Interaction between SNP rs1801198* protein 
energy intake
Interaction between SNP rs1801198* 
carbohydrate energy intake
0.832 0.100 0.489
Interaction between SNP rs4680* fat energy 
intake
Interaction between SNP rs4680* protein 
energy intake
Interaction between SNP rs4680* carbohydrate 
energy intake
0.353 0.348 0.005
Interaction between SNP rs4633* fat energy 
intake
Interaction between SNP rs4633* protein 
energy intake
Interaction between SNP rs4633* carbohydrate 
energy intake
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Interaction between SNPs and dietary factors on LDL‑ox
0.217 0.372 0.984
Interaction between SNP rs3797546* fat energy 
intake
Interaction between SNP rs3797546* protein 
energy intake
Interaction between SNP rs3797546* 
carbohydrate energy intake
0.846 0.227 0.270
Interaction between SNP rs492842* fat energy 
intake
Interaction between SNP rs492842* protein 
energy intake
Interaction between SNP rs492842* carbohydrate 
energy intake
0.624 0.466 0.690
Interaction between SNP rs602662* fat energy 
intake
Interaction between SNP rs602662* protein 
energy intake
Interaction between SNP rs602662* carbohydrate 
energy intake
0.743 0.298 0.112
P values were obtained by using a general linear model adjusted for age, sex and BMI. SNPs: Single-nucleotide polymorphisms, HDL-C: High-density 
lipoprotein-cholesterol, LDL: Low-density lipoprotein-cholesterol, BMI: Body mass index, * refers to interaction and not any significant P value
an interaction between COMT SNP rs4680 and carbohydrate 
intake on ox-LDL concentrations. Despite our study being 
the first to report this gene–diet interaction, previous studies 
have shown that carbohydrate-restricted diets can promote 
weight loss and are associated with reduced CVD risk.[38] 
However, the exact mechanism by which the COMT SNP 
rs4680 interacts with dietary carbohydrate to influence 
ox-LDL concentrations is unknown, which requires further 
studies to understand the mechanism contributing to this 
association. Furthermore, in our study, we observed an 
interaction of the FUT2 SNP rs1805087 with protein 
consumption on homocysteine levels. However, we have no 
previous studies to confirm and validate this novel finding. 
The findings in this article suggest that the inheritance of 
ox-LDL and homocysteine levels is complex, where several 
genes/polymorphisms are likely to contribute to the alteration 
of ox-LDL or homocysteine levels through gene–gene and 
gene–diet interactions. More in-depth research implementing 
animal studies, nutrigenomics and metabolomics are needed 
to clarify the effects of SNPs and carbohydrate on ox-LDL 
concentrations and protein on homocysteine concentrations, 
respectively.
One of the main limitations of our study is the small sample 
size. Given that there are no previously reported effect sizes 
for the FUT2 and COMT SNP–diet interactions on blood 
homocysteine and ox-LDL concentrations, we were unable to 
calculate the statistical power of our study. Our retrospective 
power calculation showed that the minimum detectable effects 
for ox-LDL levels ranged from beta 7.5 U/L (ox-LDL) for 
a SNP with MAF of 15% to beta 8.5 U/L for a SNP with 
MAF 50%. Hence, if the actual effect sizes were lower than 
this, our study would be underpowered. However, our study 
did find significant associations and gene–diet interactions 
despite the small sample size, but the findings require a 
replication given that the significant P values did not reach 
the Bonferroni-corrected P value. Another limitation is that 
our study was of cross sectional design, and therefore, we 
were unable to examine the causal relationship between the 
SNP–diet interactions on blood homocysteine and ox-LDL 
concentrations. Therefore, randomised controlled trials with 
prospective genotyping are required to explore the causality 
using genetic markers. Given that our study relied on a usual 
food record, we cannot negate the possibility of misreporting 
and measurement error. On the other hand, the main strength 
of our study is that we examined the effect of ten SNPs on 
Vitamin B12, folic acid, homocysteine concentrations and 
lipid traits during adolescence, a critical period where lifestyle 
habits are usually followed through to adulthood. By studying 
this population, we were able to identify different genotypes 
of interest, which could be further investigated to improve the 
understanding of the role of these micronutrients in relation 
to the prevention of hyperhomocysteinaemia and increased 
ox-LDL concentrations. In addition, little is known about 
gene–diet interactions which influence ox-LDL concentrations, 
and thus our study adds to the limited body of research.
conclusIons
Our study shows an interaction between COMT SNP rs4680 
and carbohydrate intake on ox-LDL levels among adolescents 
with cardiovascular risk factors. Furthermore, a borderline 
interaction was observed between FUT2 SNP rs602662 
and protein intake on homocysteine concentrations. After 
correction for multiple testing, none of the SNP–environment 
interactions on homocysteine, folate, Vitamin B12 or lipid 
concentrations were detected. Hence, our findings warrant 
confirmation in larger, well-characterised and well-powered 
prospective studies/randomised controlled trials, before any 
public health recommendations and personalised nutrition 
advice can be developed for the adolescent Brazilian 
population.
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Supplementary Table 1: P values for the interaction between single‑nucleotide polymorphisms and physical activity levels 
on Vitamin B12, homocysteine, folic acid and lipid traits
Gene rs number Model B12 Homocysteine Folic acid HDL LDL Triglycerides LDL‑ox
MTHFR rs1801131 Dominant 0.758 0.640 0.034 0.570 0.764 0.139 0.496
MTHFR rs1801133 Dominant 0.589 0.810 0.404 0.446 0.541 0.030 0.760
MTR rs1805087 Dominant 0.607 0.560 0.940 0.440 0.890 0.345 0.134
MTRR rs1801394 Dominant 0.106 0.325 0.238 0.956 0.915 0.701 0.563
TCN2 rs1801198 Dominant 0.414 0.321 0.941 0.517 0.726 0.186 0.887
COMT rs4680 Additive 0.543 0.058 0.783 0.537 0.663 0.113 0.681
COMT rs4633 Dominant 0.221 0.253 0.993 0.828 0.400 0.056 0.597
BHMT rs3797546 Dominant 0.146 0.274 0.255 0.811 0.250 0.209 0.050
BHMT rs492842 Additive 0.947 0.281 0.423 0.513 0.483 0.004 0.677
FUT2 rs602662 Additive 0.613 0.100 0.458 0.147 0.724 0.014 0.491
P values were obtained by using a general linear model adjusted for age, sex and BMI. HDL-C: High-density lipoprotein-cholesterol, LDL: Low-density 
lipoprotein-cholesterol, BMI: Body mass index
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